Cold Sore Tablets vs Cream UK | Treatment Comparison
Cold Sore Tablets vs Cream: Comparing Treatment Options
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
Cold Sore Tablets vs Cream: Comparing Treatment Options
Published on: June 03, 2026
When comparing cold sore tablets vs cream UK options, understanding the key differences in efficacy, convenience, and treatment duration helps you choose the most appropriate option. Both oral and topical aciclovir treatments are licensed by the MHRA for herpes simplex virus management, but they work through different mechanisms and suit different clinical scenarios.
How Aciclovir Works Against Cold Sores
Aciclovir is an antiviral medication that inhibits herpes simplex virus (HSV) replication by blocking viral DNA synthesis [1]. When HSV infects skin cells around the lips, it hijacks cellular machinery to replicate rapidly. Aciclovir converts to its active form inside infected cells, where it interferes with the viral enzyme DNA polymerase, effectively halting virus multiplication.
Both tablet and cream formulations contain the same active ingredient, but deliver it through different routes. Oral aciclovir achieves systemic distribution through the bloodstream, reaching infected tissue from within the body [1]. Topical cream works locally at the application site, penetrating the outer skin layers to target surface lesions [2].
Clinical trials demonstrate that starting aciclovir treatment during the prodromal phase—when you first notice tingling or burning sensations—produces the best outcomes, potentially preventing blister formation entirely [2]. Once blisters have fully developed, antiviral treatment primarily reduces healing time rather than preventing outbreak progression.
Oral Aciclovir Tablets: Systemic Treatment Approach
Aciclovir tablets provide systemic antiviral coverage, making them particularly effective for patients experiencing frequent or severe outbreaks [3]. The standard UK dosing regimen for cold sore treatment is 200mg taken five times daily for five days, though some prescribers may recommend 400mg three times daily as an alternative schedule.
Oral tablets reach therapeutic concentrations throughout the body within hours of the first dose, targeting the virus in nerve ganglia where HSV remains dormant between outbreaks [3]. This systemic approach can reduce viral shedding more comprehensively than topical treatment alone, potentially decreasing transmission risk during active lesions.
Patients who experience more than six cold sore episodes annually may be prescribed suppressive therapy, involving daily low-dose aciclovir to prevent recurrent outbreaks [4]. This long-term approach is only available through oral formulations, as topical creams are not suitable for continuous preventive use.
When Tablets Are Most Appropriate
UK prescribers typically recommend oral aciclovir for patients with compromised immune systems, those experiencing severe or widespread lesions, or individuals who develop cold sores in multiple facial locations simultaneously. Tablets are also preferred when cold sores extend beyond the lip border or when patients report particularly painful or prolonged outbreaks that significantly impact quality of life.
Topical Aciclovir Cream: Localised Treatment Benefits
Aciclovir 5% cream delivers concentrated antiviral medication directly to the cold sore lesion, achieving high local tissue concentrations without systemic absorption [2]. The standard application involves applying cream five times daily at approximately four-hour intervals, continuing for five days or until the lesion heals completely.
Topical treatment offers practical advantages for patients experiencing their first cold sore or those with infrequent outbreaks (fewer than three episodes per year). The cream format allows targeted application without requiring multiple daily oral doses, and avoids potential gastrointestinal side effects some patients experience with tablets.
Clinical studies indicate that topical aciclovir reduces healing time by approximately one to two days when applied during the prodromal stage [2]. However, cream formulations penetrate only the superficial skin layers, meaning they cannot address viral reservoirs in nerve tissue or provide the systemic coverage that oral tablets deliver.
Application Technique for Maximum Efficacy
Apply a thin layer of cream using a clean finger or cotton bud, covering the entire affected area plus a small margin of surrounding skin. Wash hands thoroughly before and after application to prevent viral spread to other body areas or other people. Avoid touching the cold sore unnecessarily, and never share towels, cups, or cosmetics during active outbreaks.
| Treatment Type | Active Ingredient | Dosing Frequency | Starting Price |
|---|---|---|---|
| Aciclovir Tablets | Aciclovir 200mg or 400mg | 3-5 times daily for 5 days | From £19.99 |
| Aciclovir Cream 5% | Aciclovir 5% | 5 times daily for 5 days | From £4.49 |
| Numark Cold Sore Cream | Aciclovir 5% | 5 times daily for 5 days | From £4.49 |
Cold Sore Tablets vs Cream: Direct Efficacy Comparison
Head-to-head clinical trials comparing oral versus topical aciclovir demonstrate that tablets generally produce superior outcomes for moderate to severe cold sores [3]. Oral treatment reduces median healing time by 1.5 to 2 days compared to placebo, whilst topical cream typically achieves 0.5 to 1 day reduction when applied early [2][3].
The key difference lies in bioavailability and tissue penetration. Oral aciclovir achieves therapeutic concentrations in dermal tissue, nerve ganglia, and mucosal surfaces throughout the body, whilst cream remains confined to the application site [1]. For patients experiencing their first outbreak or those with mild, infrequent episodes, topical treatment may provide adequate symptom control with fewer systemic effects.
Combination therapy—using both oral tablets and topical cream simultaneously—has not demonstrated significant additional benefit in clinical trials compared to oral treatment alone [4]. Most UK prescribers recommend choosing one approach based on outbreak severity, frequency, and patient preference rather than combining both formulations.
Side Effects and Safety Considerations
Oral aciclovir is generally well-tolerated, with the most common side effects including headache, nausea, and mild gastrointestinal discomfort affecting approximately 5-10% of patients [1]. These effects are typically mild and resolve without discontinuing treatment. Adequate hydration during oral aciclovir therapy helps maintain kidney function, particularly in patients taking higher doses or those with pre-existing renal impairment.
Topical aciclovir cream rarely causes systemic side effects due to minimal absorption through intact skin [2]. Local reactions such as mild stinging, burning, or dryness at the application site occur in fewer than 5% of users. Allergic reactions to either formulation are uncommon but require immediate discontinuation if rash, facial swelling, or breathing difficulty develops.
Pregnant and breastfeeding women can use both formulations under medical supervision, as aciclovir has an established safety profile with no evidence of teratogenic effects in human studies [4]. However, all prescription treatments require clinical assessment by a UK prescriber to ensure appropriateness for your individual circumstances.
Drug Interactions and Contraindications
Oral aciclovir has few significant drug interactions, though patients taking probenecid or mycophenolate mofetil should inform their prescriber as dose adjustments may be necessary. Topical cream has virtually no interaction potential due to negligible systemic absorption. Both formulations are contraindicated in patients with known hypersensitivity to aciclovir or valaciclovir.
Choosing Between Tablets and Cream for Your Cold Sores
Your choice between oral and topical aciclovir depends on outbreak frequency, severity, and personal circumstances. Patients experiencing more than three cold sore episodes annually typically benefit more from oral tablets, which can also be prescribed as suppressive therapy to prevent future outbreaks [4]. Those with infrequent, mild episodes may find topical cream sufficient and more convenient.
Consider oral tablets if you experience prodromal symptoms but often miss the narrow treatment window for topical application, as systemic treatment remains effective even when started slightly later in the outbreak cycle [3]. Tablets are also preferable if you have difficulty applying cream frequently throughout the day due to work or lifestyle factors.
At Cured Pharmacy, our UK-registered clinical team assesses your medical history, outbreak pattern, and treatment preferences during your free online consultation. This personalised approach ensures you receive the most appropriate aciclovir formulation for your specific needs, with transparent pricing and discreet delivery across the UK.
Scientific References
- Spruance, S. L., et al. (1990). Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrobial Agents and Chemotherapy, 34(9), 1698–1703. https://doi.org/10.1128/AAC.34.9.1698 [accessed 13 August 2026]
- Spruance, S. L., et al. (2002). Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. Journal of Infectious Diseases, 185(9), 1211–1218. https://doi.org/10.1086/340041 [accessed 13 August 2026]
- Raborn, G. W., et al. (1997). Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study. Journal of the American Dental Association, 128(9), 1265–1270. https://doi.org/10.14219/jada.archive.1997.0415 [accessed 13 August 2026]
- Rooney, J. F., et al. (1993). Oral acyclovir to suppress frequently recurring herpes labialis. A double-blind, placebo-controlled trial. Annals of Internal Medicine, 118(4), 268–272. https://doi.org/10.7326/0003-4819-118-4-199302150-00004 [accessed 13 August 2026]
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.
Trusted by thousands
Real people, real results
Jane L.
"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."
Ann-Marie
"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."
Sacha W.
"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."
Kimberly G.
"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"
Jennifer
"Great really helps cure those nasty habits can't wait for my next mounjaro pen."
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Faq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.